Peptide design
CYPRESS performs in-silico peptide design from hotspot identification through MD validation.
Source: LinkedIn company description · Retrieved October 13, 2026
DiaGen AI builds AI platforms for identifying small molecules and peptides.
BLACKCOMB designs small molecules using an atomic-resolution model trained on compounds, generating analogs around lead and patent chemistry. CYPRESS runs peptide design in silico from hotspot identification to MD validation.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
The company works through partners including Hadassah/Hadasit, Ariel University, UNC-SGC, Mila – Quebec AI Institute, AKT Health, and MetaNova Labs.
CYPRESS performs in-silico peptide design from hotspot identification through MD validation.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 3, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 3, 2026, September 5, 2026, September 6, 2026, September 21, 2026 and September 26, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.